ALTO vs DGX · P/E 13, rev $470.4M vs P/E 22, rev $5.94B
Alto Ingredients Inc (ALTO) versus Quest Diagnostics Incorporated (DGX) — a side-by-side from cached financials, not a winner call.
Alto Ingredients Inc (ALTO) is a specialty chemicals company listed on NASDAQ.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Latest reported ALTO revenue for 2026-06-30 was $470.4M. Net income was $16.0M. ALTO currently screens at market cap $383.6M and trailing P/E 13.4.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
ALTO currently screens at market cap $383.6M and trailing P/E 13.4. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Not investment advice. Open the ALTO and DGX stock pages for the full models.
Not investment advice.